Patent · US Expired

9-[3-(4-Phenoxymethylpiperidino)-propyl]-adenines

US4086347A · kind A · utility

9Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 1976
Grant dateApr 25, 1978
Priority date
Expiry dateNov 2, 1996

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

9-[3-(4-Phenoxymethylpiperidino)-propyl]-adenines of the formula ##STR1## wherein R.sub.1 is a hydrogen atom or a lower alkyl radical, PA1 R.sub.2 is a hydrogen atom, a ower alkyl radical optionally substituted by hydroxyl, or a cycloalkyl radical, or PA1 R.sub.1 and R.sub.2 together with the nitrogen atom to which they are attached form a heterocyclic ring, and PA1 R.sub.3 is a hydrogen atom, a halogen atom, a lower alkyl radical or a lower alkoxy radical, In the form of the free base or a salt thereof, exhibit anti-allergic, anti-inflammatory, anti-oedematous and anti-hypertensive activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.